Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

Fig. 2

Signal strength of samples with a positive test result on HC2, cobas, or APTIMA. Test results are stratified by whether CLART detected at least one of the high-risk genotypes, only low-risk genotypes, or no genotypes. Medians with interquartile ranges (IQR). HC2: High-risk genotypes (n = 866), median = 28.1, IQR: 5.6 to 157.4. Low-risk genotypes (n = 109), median = 5.2, IQR: 2.2 to 24.1. No genotypes (n = 49), median = 3.0, IQR: 1.7 to 8.8. cobas: High-risk genotypes (n = 1121), median = 31.1, IQR: 27.1 to 35.0. Low-risk genotypes (n = 62), median = 37.8, IQR: 34.2 to 38.9. No genotypes (n = 162), median = 38.9, IQR: 36.2 to 39.5. APTIMA: High-risk genotypes (n = 747), median = 10.8, IQR: 8.0 to 12.4. Low-risk genotypes (n = 35), median = 5.4, IQR: 1.5 to 8.9. No genotypes (n = 56), median = 3.2, IQR: 1.3 to 7.3

Back to article page